Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder

Background and objective: GATA3, an emerging immunohistochemical marker, is a zinc finger transcription factor that is expressed in normal urothelial epithelium and its corresponding neoplasms, and it has been recognized as a reliable urothelial related immunohistochemical marker. This study aimed t...

Full description

Saved in:
Bibliographic Details
Main Authors: Shadan Abdulkhaliq Jaf, Jalal Ali Jalal
Format: Article
Language:English
Published: Hawler Medical University 2024-12-01
Series:Zanco Journal of Medical Sciences
Subjects:
Online Access:https://zjms.hmu.edu.krd/index.php/zjms/article/view/945
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846116254329339904
author Shadan Abdulkhaliq Jaf
Jalal Ali Jalal
author_facet Shadan Abdulkhaliq Jaf
Jalal Ali Jalal
author_sort Shadan Abdulkhaliq Jaf
collection DOAJ
description Background and objective: GATA3, an emerging immunohistochemical marker, is a zinc finger transcription factor that is expressed in normal urothelial epithelium and its corresponding neoplasms, and it has been recognized as a reliable urothelial related immunohistochemical marker. This study aimed to detect the frequency of GATA3 expression in urothelial carcinoma of urinary bladder and determine its association with some clinicopathologic parameters. Methods: Seventy-nine formalin fixed paraffin embedded blocks of urothelial carcinoma cases were randomly selected from a private laboratory in Erbil city during October 2019 to October 2021. In this study, GATA3, a Rabbit monoclonal antibody was applied on urothelial carcinoma cases and its expression was assessed. Results: GATA3 was expressed in 94.9% of the study cases. It was expressed in all non-invasive and low-grade urothelial carcinoma cases and 97.1% of papillary urothelial carcinoma cases, while it down-expressed in high-grade, invasive and non-papillary urothelial carcinoma cases. A significant association was noted between GATA3 expression and tumor pattern (P = 0.034), while no significant association was noted between GATA3 expression and other clinicopathologic parameters like age, gender, tumor grade, lympho-vascular invasion and tumor stage. Conclusion: GATA3 is a useful diagnostic immunohistochemical marker for urothelial carcinoma, as this marker was expressed in 94.9% of urothelial carcinoma cases with a significant association with tumor pattern. Further studies are required to evaluate GATA3 expression in association with urothelial cancer progression and metastasis.
format Article
id doaj-art-8bea3a381f4e4f57a49567df6f29ac58
institution Kabale University
issn 1995-5588
1995-5596
language English
publishDate 2024-12-01
publisher Hawler Medical University
record_format Article
series Zanco Journal of Medical Sciences
spelling doaj-art-8bea3a381f4e4f57a49567df6f29ac582024-12-19T06:47:29ZengHawler Medical UniversityZanco Journal of Medical Sciences1995-55881995-55962024-12-0128337738510.15218/zjms.2024.36Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladderShadan Abdulkhaliq Jaf0Jalal Ali Jalal1Department of Histopathology, Rizgary Teaching Hospital, Erbil, Iraq.Department of Basic Sciences/Pathology, College of Medicine, Hawler Medical University, Erbil, Iraq.Background and objective: GATA3, an emerging immunohistochemical marker, is a zinc finger transcription factor that is expressed in normal urothelial epithelium and its corresponding neoplasms, and it has been recognized as a reliable urothelial related immunohistochemical marker. This study aimed to detect the frequency of GATA3 expression in urothelial carcinoma of urinary bladder and determine its association with some clinicopathologic parameters. Methods: Seventy-nine formalin fixed paraffin embedded blocks of urothelial carcinoma cases were randomly selected from a private laboratory in Erbil city during October 2019 to October 2021. In this study, GATA3, a Rabbit monoclonal antibody was applied on urothelial carcinoma cases and its expression was assessed. Results: GATA3 was expressed in 94.9% of the study cases. It was expressed in all non-invasive and low-grade urothelial carcinoma cases and 97.1% of papillary urothelial carcinoma cases, while it down-expressed in high-grade, invasive and non-papillary urothelial carcinoma cases. A significant association was noted between GATA3 expression and tumor pattern (P = 0.034), while no significant association was noted between GATA3 expression and other clinicopathologic parameters like age, gender, tumor grade, lympho-vascular invasion and tumor stage. Conclusion: GATA3 is a useful diagnostic immunohistochemical marker for urothelial carcinoma, as this marker was expressed in 94.9% of urothelial carcinoma cases with a significant association with tumor pattern. Further studies are required to evaluate GATA3 expression in association with urothelial cancer progression and metastasis.https://zjms.hmu.edu.krd/index.php/zjms/article/view/945urothelial carcinomagata3immunohistochemistry
spellingShingle Shadan Abdulkhaliq Jaf
Jalal Ali Jalal
Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
Zanco Journal of Medical Sciences
urothelial carcinoma
gata3
immunohistochemistry
title Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
title_full Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
title_fullStr Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
title_full_unstemmed Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
title_short Immunohistochemical expression of GATA3 in urothelial carcinoma of urinary bladder
title_sort immunohistochemical expression of gata3 in urothelial carcinoma of urinary bladder
topic urothelial carcinoma
gata3
immunohistochemistry
url https://zjms.hmu.edu.krd/index.php/zjms/article/view/945
work_keys_str_mv AT shadanabdulkhaliqjaf immunohistochemicalexpressionofgata3inurothelialcarcinomaofurinarybladder
AT jalalalijalal immunohistochemicalexpressionofgata3inurothelialcarcinomaofurinarybladder